Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

8.900 +0.080 (+0.91%)
Official Closing Price Updated: 8:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
39 40 Next >
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) and Clinilabs Drug Development Corporation (Clinilabs) announced that the U.S. 
Via Benzinga
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial
From Cybin Inc.
Via Business Wire
Psychedelic Stock Gainers And Losers From August 16, 2022
  
Via Benzinga
These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst
HC Wainwright expects COMPASS Pathways Plc (NASDAQ: CMPS) and Cybin Inc (NYSE: CYBN) to be leaders in the emerging $400 billion mental healthcare market. 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Results of Annual Meeting of Shareholders
Via Investor Brand Network
Cybin Announces Results of Shareholders’ Meeting
From Cybin Inc.
Via Business Wire
Allied, Cybin Among Top Psychedelic Movers Of Today
  
Via Benzinga
Major Psychedelic Stocks Down This Week; Still Up Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then. 
Via Talk Markets
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today
  
Via Benzinga
Psilocybin Lawsuit Filed in Canada May Boost Global Psychedelics Reform Efforts
Via Investor Brand Network
Topics Lawsuit
Exposures Financial Legal
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
  
Via Benzinga
Brain Fingerprinting Adolescents Could Predict Future Mental-Health Issues
Via Investor Brand Network
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... 
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
3 Best Psychedelic Stocks to Buy Now
These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders. 
Via InvestorPlace
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) has launched an at-the-market (ATM) equity program through which it will issue and sell up to $35 million in common shares in the company’s capital, from the... 
Via Benzinga
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
  
Via Benzinga
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unveils Equity Program, Releases Q1 Financial Report
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program
From Cybin Inc.
Via Business Wire
Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights
From Cybin Inc.
Via Business Wire
Toronto Firm Receives First Federal Government Funding to Study Psilocybin
Via Investor Brand Network
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program
Via Investor Brand Network
New Poll Finds Most Americans Support Research on Psychedelics for Military Members
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
Study Finds That Difficulty Sleeping, Financial Stressors Increase Mental Health Risk in University Students
Via Investor Brand Network
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback